Survival and Prognostic Factors in Systemic Sclerosis–Associated Pulmonary Hypertension: A Systematic Review and Meta‐Analysis

Archive ouverte

Lefèvre, Guillaume | Dauchet, Luc | Hachulla, Eric | Montani, David | Sobanski, Vincent | Lambert, Marc | Hatron, Pierre-Yves | Humbert, Marc | Launay, David | Hatron, Pierre‐yves

Edité par CCSD ; Wiley -

International audience. Objective Pulmonary hypertension (PH) is a frequent and life‐limiting complication of systemic sclerosis (SSc). However, data on survival rates and their evolution over time, as well as prognostic factors in SSc complicated by PH, are still conflicting. The aim of this study was to conduct a systematic review and meta‐analysis of cohort studies to assess pooled survival and prognostic factors for survival in patients with SSc–associated PH. Methods For this systematic review and meta‐analysis, we searched the Medline and EMBase databases (January 1960 to January 2012). All cohort studies in which survival and/or prognostic factors for SSc–associated PH were reported were included in the analysis. We calculated the pooled survival rates and analyzed their evolution over time and identified prognostic factors for survival. Results Twenty‐two studies were included, representing a total of 2,244 patients with SSc–associated PH. The pooled 1‐, 2‐, and 3‐year survival rates were 81% (95% confidence interval [95% CI] 79–84%), 64% (95% CI 59–69%), and 52% (95% CI 47–58%), respectively. Meta‐regression did not reveal a significant change in survival over time, while baseline hemodynamic measures of PH severity were significantly correlated with survival. In patients with SSc complicated by pulmonary arterial hypertension (PAH), age, male sex, diffusing capacity for carbon monoxide (DL CO ), pericardial effusion, and the parameters classically associated with the severity of idiopathic PAH, including the 6‐minute walk distance, mean pulmonary artery pressure, cardiac index, and right atrial pressure, were significant prognostic factors. DL CO and pericardial effusion were the only prognostic factors in patients with interstitial lung disease–related PH. Conclusion Our meta‐analysis revealed a poor pooled 3‐year survival rate of 52% in patients with SSc–associated PH. Baseline hemodynamic measures of PAH severity, but not the period of time during which patients were included in the studies, correlated significantly with survival in patients with SSc–associated PAH. All of the prognostic factors typically observed in idiopathic PAH, including the 6‐minute walk distance and right atrial pressure, were also prognostic factors in SSc–associated PAH.

Consulter en ligne

Suggestions

Du même auteur

Prevalence of Anti–RNA Polymerase III Antibodies in Systemic Sclerosis: New Data From a French Cohort and a Systematic Review and Meta‐Analysis

Archive ouverte | Sobanski, Vincent | CCSD

International audience. Objective Studies assessing the prevalence of anti–RNA polymerase III (anti–RNAP III) antibodies in systemic sclerosis (SSc) have yielded a wide range of results. The aim of the present study...

Clinical Phenotype of Systemic Sclerosis Patients with Anti-RNA Polymerase III Antibodies: A New French Cohort, Systematic Review and Meta-Analysis

Archive ouverte | Sobanski, Vincent | CCSD

International audience. For a searchable version of these abstracts, please visit www.acrabstracts.org .

Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severity

Archive ouverte | Lanteri, Aurélia | CCSD

International audience. Systemic sclerosis (SSc) is a chronic autoimmune connective tissue disease. Humoral immunity and B cells are thought to play an important role in the pathophysiology of the disease. B cells a...

Chargement des enrichissements...